相关实验视频
Updated: Jul 10, 2026
10:45
Histological Analyses of Acute Alcoholic Liver Injury in Zebrafish
Published on: May 25, 2017
14.2K
拜卡林通过SOCS1驱动的巨细胞重编程来减轻与酒精有关的肝病
Sha Huang1,2,3, Yuhua Wang4, Jinjie Wen4
1School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510515, Guangdong, China. hstcm2018@163.com.
Chinese medicine
|May 13, 2025
概括
拜卡林 (BA) 通过增加巨细胞中细胞因子信号传递1 (SOCS1) 的抑制剂来治疗酒精性肝病 (ALD). 这项研究揭示了BABA.
科学领域:
- 肝病学和免疫学 肝病学和免疫学
- 药理学 药理学是指药理学的学科.
- 在疾病研究中的斑马鱼模型.
背景情况:
- 酒精性肝病 (ALD) 具有显著的死亡率,没有有效的药理疗法.
- 巴伊卡林 (BA) 是一种黄类化合物,对保护肝脏有很大的前景.
- 对BA对肝脏免疫细胞,特别是SOCS1和巨细胞的影响的精确机制需要进一步阐明.
研究的目的:
- 为了研究Baicalin (BA) 对酒精性肝病 (ALD) 的治疗作用.
- 为了澄清细胞因子信号传递1 (SOCS1) 抑制剂在ALD的背景下巨细胞分化中的作用.
- 探索BA,SOCS1和巨细胞重编程在肝免疫中的相互作用.
主要方法:
- 使用斑马鱼作为体内模型来研究酒精性肝病 (ALD).
- 采用基因淘汰和过度表达技术来研究分子机制.
- 分析了关键的巨细胞标记物 (CD86,CD80,iNOS,CD206,CD163) 和细胞因子 (IL-4,IL-10) 的表达.
主要成果:
- 拜卡林 (BA) 在体内和体外模型中显著改善了酒精性肝病 (ALD).
- BA治疗导致巨细胞中抑制细胞因子信号传递1 (SOCS1) 表达的上调.
- SOCS1调节与巨细胞重编程直接相关,影响炎症和抗炎症标志物.
结论:
- 贝卡林 (BA) 证明了酒精性肝病 (ALD) 的治疗潜力.
- 该机制涉及SOCS1的上调,导致巨细胞重编程.
- 准SOCS1介导的巨细胞通路代表了ALD的有前途的治疗策略.
更多相关视频
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
710
08:37Assessment of Glutamine as a Fuel Source for Alveolar Macrophages Exposed to Chronic Ethanol Using an Extracellular Flux Bioanalyzer
Published on: November 15, 2024
235
相关概念视频
01:24Liver Regeneration
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...